Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III studyVito Lorusso, Giuseppe Colucci, Francesco Giotta et al.|International Journal of Oncology|2014Cited by 26
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experienceMariangela Ciccarese, Giammarco Surico, Alessandra Fabi et al.|Breast Cancer Research and Treatment|2017Cited by 12
SAT0461 SHORT-TERM MONITORING OF DENOSUMAB EFFECT IN BREAST CANCER PATIENTS RECEIVING AROMATASE INHIBITORS USING REMS TECHNOLOGY ON LUMBAR SPINEE. Quarta, Sergio Casciaro, D. Ciardo et al.|Annals of the Rheumatic Diseases|2020Cited by 5
Vinorelbine plus capecitabine in salvage therapy of breast cancer. Comparison of intravenous vs oral administration of vinorelbineVito Lorusso, Corrado Manca, R. Forcignanò et al.|Journal of Clinical Oncology|2008Cited by 5
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA StudyMarina Elena Cazzaniga, Giorgio Mustacchi, P. Pronzato et al.|Cancers|2023Cited by 2